Blog Archive
New Referral Process We are excited to announce that we have a new referral upload form available for your convenience. You can now easily refer your patients to us by faxing over the attached form. We understand that many practices prefer to share referrals via fax or within your EMR...
We are thrilled to share that the FDA has granted approval for Leqembi, a groundbreaking drug that offers new hope for Alzheimer's patients. Leqembi is an antibody that targets amyloid in the brain, in order to slow the progress of Alzheimer’s. This approval is a significant achievement, particularly for our...
NDx is excited to announce our contribution to Lilly's ALZ 2 Trailblazer trial, which began in July 2020. We've been working with patients in this trial and have enrolled 39 patients, out of the total of over 1700 enrolled since the start of the trial! We are proud to report...
April is Parkinson's Awareness Month, a time when people worldwide come together to raise awareness of Parkinson's disease and the impact it has on millions of people and their families. Parkinson's disease is a long-term illness that affects many people worldwide, causing problems with movement such as shaking, stiffness, and...
We are thrilled to announce that our very own Dr. Joel Vandersluis has been selected as a 2023 Health Care Hero! This prestigious recognition celebrates those who have made significant contributions to health care through their concern for patients, their research and inventions, their management skills, their innovative programs for...
What is clinical research? Clinical research is a medical research involving people. It is a branch of science that helps us gain knowledge about the disease progression, new medical drugs, procedures or devices. There are two types of clinical research: Clinical trial is an interventional study. It tests the safety...
Parkinson's disease afflicts over one million people in the United States. This disabling disease is the result of the destruction of neurons producing dopamine. Dopamine is vital to our normal every day functions; from how you move your body, to how your mind controls your thoughts. As the disease progresses...
The Eli Lilly Alzheimer's Phase 2 clinical trial shows promising results and success in slowing the decline seen in dementia patients. The New York Times reported on the success of the small clinical trial by Eli Lilly and Company January 11, 2021. Neurology Diagnostics proudly announces that we are a top...